An observational study of the efficacy of cisatracurium compared with vecuronium in patients with or at risk for acute respiratory distress syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 197, Issue 7, 2018, Pages 897-904

  Sottile, Peter D ^a   Kiser, Tyree H ^b   Burnham, Ellen L ^a   Ho, P Michael ^a   Allen, Richard R ^c   Vandivier, R William ^a   Moss, Marc ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Peak Statistical Services   (United States)

Author keywords

Acute respiratory distress syndrome; Mechanical ventilators; Neuromuscular blockade; Patient outcome assessment

Indexed keywords

CISATRACURIUM; VECURONIUM; ATRACURIUM BESILATE; NEUROMUSCULAR BLOCKING AGENT;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; COHORT ANALYSIS; COMORBIDITY; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; ELIXHAUSER COMORBIDITY INDEX; FEMALE; HOSPITAL ADMISSION; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; NEUROMUSCULAR BLOCKING; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK; VENTILATOR INDUCED LUNG INJURY; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; COMPARATIVE STUDY; RISK; TREATMENT OUTCOME;

ATRACURIUM; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKING AGENTS; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK; TREATMENT OUTCOME; VECURONIUM BROMIDE;

EID: 85045209040     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201706-1132OC     Document Type: Review

References (30)

1. Ashbaugh DG, BigelowDB, Petty TL, Levine BE. Ashbaugh DG, BigelowDB, Petty TL, Levine BE. Acute respiratory distress in adults. The Lancet, Saturday 12 August 1967 [review of the classics]. Crit Care Resusc 2005;7:60-61.
2. Webb HH, Tierney DF. Experimental pulmonary edema due to intermittent positive pressure ventilation with high inflation pressures: protection by positive end-expiratory pressure. Am Rev Respir Dis 1974;110:556-565.
3. Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A; Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-1308.
4. Futier E, Constantin J-M, Paugam-Burtz C, Pascal J, Eurin M, Neuschwander A, et al.; IMPROVE Study Group. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med 2013;369:428-437.
5. Serpa Neto A, Cardoso SO, Manetta JA, Pereira VGM, Espósito DC, Pasqualucci MDOP, et al. Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome: a meta-analysis. JAMA 2012;308:1651-1659.
6. Guay J, Ochroch EA. Intraoperative use of low volume ventilation to decrease postoperative mortality, mechanical ventilation, lengths of stay and lung injury in patients without acute lung injury. Cochrane Database Syst Rev 2015;12:CD011151.
7. Neto AS, Simonis FD, Barbas CSV, Biehl M, Determann RM, Elmer J, et al.; PROtective Ventilation Network Investigators. Lung-protective ventilation with low tidal volumes and the occurrence of pulmonary complications in patients without acute respiratory distress syndrome: a systematic review and individual patient data analysis. Crit Care Med 2015;43: 2155-2163.
8. Brochard L, Slutsky A, Pesenti A. Mechanical ventilation to minimize progression of lung injury in acute respiratory failure. Am J Respir Crit Care Med 2017;195:438-442.
9. Papazian L, Forel J-M, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, et al.; ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010;363: 1107-1116.
10. Price D, Kenyon NJ, Stollenwerk N. A fresh look at paralytics in the critically ill: real promise and real concern. Ann Intensive Care 2012;2:43.
11. Red Book Online. Greenwood Village, CO: Truven Health Analytics [accessed 2016 Apr 4]. Available from: http://micromedex. com/products/product-suites/clinical-knowledge/redbook.
12. Lindenauer PK, Pekow PS, Lahti MC, Lee Y, Benjamin EM, RothbergMB. Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA 2010;303:2359-2367.
13. Mercaldi CJ, Reynolds MW, Turpin RS. Methods to identify and compare parenteral nutrition administered from hospital-compounded and premixed multichamber bags in a retrospective hospital claims database. JPEN J Parenter Enteral Nutr 2012;36:330-336.
14. Barnett NP, Apodaca TR, Magill M, Colby SM, Gwaltney C, Rohsenow DJ, et al. Moderators and mediators of two brief interventions for alcohol in the emergency department. Addiction 2010;105:452-465.
15. Schneeweiss S, Seeger JD, Landon J, Walker AM. Aprotinin during coronary-artery bypass grafting and risk of death. N Engl J Med 2008;358:771-783.
16. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 2007;369:1553-1564.
17. Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al.; LUNG SAFE Investigators; ESICM Trials Group. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016;315:788-800.
18. Munshi L, Gershengorn HB, Fan E, Wunsch H, Ferguson ND, Stukel TA, et al. Adjuvants to mechanical ventilation for acute respiratory failure: adoption, de-adoption, and factors associated with selection. Ann Am Thorac Soc 2017;14:94-102.
19. Kiser TH, Allen RR, Valuck RJ, Moss M, Vandivier RW. Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2014;189:1052-1064.
20. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998;36:8-27.
21. Rassen JA, Doherty M, Huang W, Schneeweiss S. Pharmacoepidemiology toolbox; 2013 [accessed 2017 May 1]. Available from: http://www.hdpharmacoepi.org.
22. Sottile P, Kiser TH, Burnham EL, Ho M, Allen RR, Vandivier RW, et al. Mortality in intubated patients treated with vecuronium or cisatracurium [abstract]. Am J Respir Crit Care Med 2017;195: A2779.
23. Forel J-M, Roch A, Marin V, Michelet P, Demory D, Blache J-L, et al. Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med 2006;34:2749-2757.
24. Steingrub JS, Lagu T, Rothberg MB, Nathanson BH, Raghunathan K, Lindenauer PK. Treatment with neuromuscular blocking agents and the risk of in-hospital mortality among mechanically ventilated patients with severe sepsis. Crit Care Med 2014;42: 90-96.
25. Slutsky AS. Neuromuscular blocking agents in ARDS. N Engl J Med 2010;363:1176-1180.
26. Prielipp RC, Coursin DB, Scuderi PE, Bowton DL, Ford SR, Cardenas VJ Jr, et al. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients. Anesth Analg 1995;81:3-12.
27. Herridge MS, Tansey CM, Matté A, Tomlinson G, Diaz-Granados N, Cooper A, et al.; Canadian Critical Care Trials Group. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med 2011;364:1293-1304.
28. Ogburn EL, VanderWeele TJ. On the nondifferential misclassification of a binary confounder. Epidemiology 2012;23:433-439.
29. Di Martino M, Fusco D, Colais P, Pinnarelli L, Davoli M, Perucci CA. Differential misclassification of confounders in comparative evaluation of hospital care quality: caesarean sections in Italy. BMC Public Health 2014;14:1049.
30. Funk MJ, Landi SN. Misclassification in administrative claims data: quantifying the impact on treatment effect estimates. Curr Epidemiol Rep 2014;1:175-185.